Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation.
Institute of Medical Sciences and Department of Medicine, Tokai, University School of Medicine, Kanagawa, Japan. t-miyata@is.icc.u-tokai.ac.jp
Toshio
T
Miyata
Charles
C
van Ypersele de Strihou
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology*; D016166:Free Radical Scavengers; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors*; D006801:Humans; D008954:Models, Biological; D028561:Transition Elements / Q000494:pharmacology*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002614:Chelating Agents; D016166:Free Radical Scavengers; D017127:Glycation End Products, Advanced; D028561:Transition Elements